Garopride 50 mg 30 tablets

Garopride 50 mg 30 tablets

Composition:

Each tablet contains:
Active ingredient: Itopride hydrochloride – 50 mg

Product Description:

• Garopride is a gastroprokinetic medicine for oral use.
• It improves gastric motility and coordination by increasing acetylcholine levels in the gastrointestinal tract. 
• The immediate‑release tablet form ensures rapid onset of action. 
• Garopride also has antiemetic properties due to its effect on dopamine receptors in the brain.

Indications for Use:

Treatment of gastrointestinal symptoms associated with impaired gastric motility or delayed gastric emptying, such as:

• Abdominal bloating,
• Early satiety,
• Postprandial fullness,
• Epigastric pain or discomfort,
• Loss of appetite,
• Heartburn,
• Nausea,
• Vomiting Functional (non‑ulcer) dyspepsia or chronic gastritis.

Method of Administration and Dosage:

Adults: 1 tablet (50 mg) orally, 3 times daily before meals.
Recommended daily dose: 150 mg.
Dose may be reduced depending on age and symptoms.
Clinical studies: treatment duration up to 8 weeks.

Contraindications:

• Gastrointestinal bleeding, mechanical obstruction, or perforation.
• Pregnancy.
• Lactation (breastfeeding).
• Children under 16 years (safety data unavailable).
• Hypersensitivity to itopride or excipients.

Precautions:

Itopride enhances acetylcholine activity and may cause cholinergic adverse reactions.

Adverse Reactions (Side Effects):

• Gastrointestinal: common – abdominal pain, diarrhea;
  uncommon – hypersalivation
• Laboratory findings: uncommon – elevated ALT, leukopenia
• Nervous system: uncommon – dizziness, headache
• Skin: uncommon – rash

Pregnancy and Lactation:

Not recommended during pregnancy or breastfeeding.

Storage Conditions:

Store at temperatures not exceeding 30°C.

Packaging:

Carton box containing 3 blisters of 10 tablets each, with paper leaflet.